Healthcare News and Headlines
Healthcare News and Headlines
Digital Workforce, a Helsinki‑based automation firm, serves over 200 large organizations and targets roughly $40 million in revenue this year. Its flagship Outsmart platform blends robotic process automation and AI to run entire patient‑care pathways, with a particular emphasis on healthcare and social‑care automation. The company recently closed a $1.4 million contract with a top‑five East Coast academic health system, marking its first lighthouse U.S. customer. Following a UK NHS‑focused acquisition, Digital Workforce is actively expanding its U.S. footprint, targeting revenue‑cycle management and broader clinical automation.
Researchers at Washington University School of Medicine and Children’s Hospital of Philadelphia have demonstrated that volatile organic compounds (VOCs) in exhaled breath mirror gut microbiome activity. Published in Cell Metabolism, the proof‑of‑concept study showed breath profiles could differentiate children with...
GXO Logistics has been selected by NHS England to manage the supply and distribution of home testing kits for the national bowel cancer screening programme, specifically the Faecal Immunochemical Test (FIT). The logistics firm will act as a managed service...
A 2023 American Dental Association survey shows nearly 80% of adults are dissatisfied with their tooth color, yet only 15% seek professional whitening, fueling a surge in at‑home solutions. Professional treatments cost $300‑800 per session, while over‑the‑counter strips, gels, and...
STAT’s analysis of the 50 largest publicly traded health‑care firms shows that job growth at these for‑profit giants has stalled over the past five years, even as the broader health‑care sector continues to expand the U.S. labor market. Health insurers...
Japan is experiencing a nationwide shortage of Concerta, the primary stimulant used to treat adult ADHD, as demand surges. The shortage, first noted in late 2023, persists despite Janssen Pharmaceutical’s promise of a two‑month fix, with officials now estimating several...
On Jan. 20, 2025 President Donald Trump signed an executive order that recognizes only two sexes and mandates federal agencies use the term “sex” instead of “gender.” The order abruptly removed the NIH Sex as a Biological Variable (SABV) policy webpages, unsettling...
Nearly a year after the UK outlawed single‑use disposable vapes, new data show only modest health and environmental gains. Vaping prevalence remains at 5.4 million adults, with no clear reduction in smoking‑related illnesses. Waste audits indicate a roughly 15 percent drop in...
Strength training is positioned as a modifiable lever to counter frailty, using the Rockwood Clinical Frailty Scale (CFS) to tailor exercise intensity. The article outlines a three‑level prescription matrix—supported, standard, and power—matched to CFS bands, recommending 4‑6 core movements performed...
A frontline health centre in Kaita, Katsina state, run by the Alliance for International Medical Action (Alima), is treating thousands of children suffering acute malnutrition as Nigeria’s hunger crisis deepens. The Red Cross warns up to 33 million Nigerians could face...
The Agency for Healthcare Research and Quality (AHRQ) received $345 million from Congress for FY 2026, yet it has not awarded any new research grants since the fiscal year began in October 2025. Staffing cuts under the Trump administration have gutted the agency’s...
Hong Kong Polytechnic University researchers have built EyeAgent 1.0, a multimodal AI system that can recognize roughly 260 eye conditions using over 2.7 million images and 23 data types. The prototype cut diagnosis time by 56.8% and boosted detection rates by 24.5%,...
Ayala’s healthcare arm AC Health emerged as the only Philippine group honored in both hospital and pharmaceutical categories at the Healthcare Asia Awards, securing multiple accolades for its subsidiaries Healthway Medical Network, Generika Drugstore, MedEthix, and IE Medica. Healthway earned Patient Care...
Kailera Therapeutics, one of biotech’s best‑funded startups, announced plans to go public to finance the Phase 3 trial of its obesity drug co‑developed with China’s Hengrui. The IPO aims to raise capital that will position the company against heavyweight rivals such...
The SPIRIT‑HF trial, designed to test spironolactone in heart‑failure patients with preserved or mildly reduced ejection fraction, enrolled only 730 of the planned 1,564 participants and therefore lacked statistical power. Over two years, the composite of cardiovascular death or total...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-951246244-aafb86a3556145b8b2ad04415d62b09b.jpg)
Antidepressant prescriptions remain among the most common in the United States, with selective serotonin reuptake inhibitors (SSRIs) accounting for roughly 70 % of all treatments. Recent surveys show that more than 14 % of Americans aged 12 and older used an antidepressant...
Superbug resistance is accelerating worldwide, with the World Health Organization warning that one in six infection‑causing microbes now defy antibiotics. Between 2018 and 2023, resistance rose in over 40% of monitored pathogen‑drug pairings, averaging a 5‑15% annual increase. The WHO...
Jefferies has initiated coverage of Vor Biopharma with a buy rating and a $50 price target, far above the current $14.48 share price. The company recently pivoted to autoimmune diseases, licensing telitacicept for lupus, rheumatoid arthritis, and myasthenia gravis, and...
Merck announced that its experimental drug Winrevair will move into a pivotal Phase 3 trial for a rare form of heart failure, focusing on the lowest dose tested in Phase 2. The Phase 2 data showed a "pretty profound" efficacy signal at that...
Researchers at Yale School of Medicine have devised a blood test that reads epigenetic methylation patterns in white‑blood cells to predict which endometriosis patients will respond to progesterone‑based birth control. The study examined 31 women, identified over 1,400 differentially methylated...
At the American Academy of Dermatology 2026 meeting, researchers presented TRACE, a real‑world study of tralokinumab in atopic dermatitis. The trial enrolled over 800 patients, with roughly 16% representing skin‑of‑color individuals (Fitzpatrick types 4‑6). After 12 months, 80% of this subgroup achieved...
A community health worker‑led, barbershop‑based program aimed at preventing hypertension in Black men was evaluated in a cluster‑randomized trial across 22 barbershops involving 430 participants. The primary endpoint—change in systolic blood pressure over 12 months—showed no significant reduction in either...
The University of Chicago Medicine opened a Level 1 trauma center in May 2018, cutting average transport time for gunshot victims by roughly ten minutes and distance by 3.4 miles. An analysis of more than 45,000 Chicago shootings from 2010‑2024 showed a 3.9%...
A new global review highlights stark differences in how nations regulate polygenic embryo testing, a rapidly expanding extension of pre‑implantation genetic testing (PGT). While the United States has permitted commercial polygenic screening since 2019, many European countries limit testing to...
A recent International Myeloma Society summit introduced a formal definition of "cure" for multiple myeloma, sparking debate among oncologists, patients, and advocates. Advances such as CAR‑T cell therapy have pushed five‑year survival rates to 62%, prompting some clinicians to label...
A statistician highlights the difficulty of judging scientific evidence, contrasting p‑values and e‑values that can lead to opposite conclusions about the same data. He argues that thresholds for significance are subjective, turning gray‑area findings into binary claims. The piece warns...
Topical immunotherapy using contact allergens such as diphenylcyclopropenone (DPCP) or squaric acid dibutyl ester (SADBE) remains an effective, affordable option for alopecia areata, even as high‑cost JAK inhibitors dominate headlines. A recent Frontiers in Medicine case series of five chronic...
Healthcare leaders face mounting financial strain from workforce shortages, Medicaid cuts and the One Big Beautiful Bill Act, which could generate $200 billion in uncompensated care by 2034. While clinical costs dominate attention, non‑clinical expenses such as IT, facilities and corporate...
Researchers report that Richter transformation (RT) can be identified years before clinical onset in chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) patients through multi‑omics profiling of tiny subclones. Current anthracycline‑based chemoimmunotherapy delivers median overall survival under one year,...
The article breaks down how patients can cut prescription costs amid a growing maze of discount options, from brand‑name sites like TrumpRx to coupon‑heavy platforms such as GoodRx and Cost Plus Drugs. It highlights the stark price gap between brand drugs—e.g., Protonix...
A new JAMA Internal Medicine study examined over 386,000 adults to assess whether caffeine intake influences arrhythmia risk. After adjusting for genetic differences in caffeine metabolism, researchers found no evidence that higher coffee consumption raises the likelihood of irregular heartbeats....
Emerging diabetes therapies are reshaping treatment of metabolic dysfunction‑associated steatotic liver disease (MASLD), especially its severe form MASH. GLP‑1 receptor agonists such as semaglutide and dual‑action agents like tirzepatide have shown significant liver‑fat reduction and histologic improvement. SGLT2 inhibitors and...
A recent study in the Journal of the American Heart Association found that a five‑minute high‑resistance inspiratory muscle strength training (IMST) protocol can lower systolic blood pressure by about nine points in adults aged 50 to 79. The intervention, performed...
The NNPC/Seplat joint venture’s “Eye Can See” corporate social investment program in Imo State has delivered 23,447 free eye screenings, performed 797 cataract surgeries, and distributed over 13,525 glasses since its 2017 launch. The three‑day outreach in Owerri, held March...
Kaiser Permanente reported a $9.3 billion profit on $127 billion revenue, while its cash reserves swelled to $73 billion. The nonprofit settled a $556 million Medicare fraud case and a $30 million mental‑health lawsuit, both without admitting wrongdoing. Rising premiums, staff shortages and a 30,000‑person...
High‑quality scalers curette sets and extracting forceps are essential for modern dental practice. These instruments provide sharp, ergonomic designs that improve plaque removal, precise tooth extractions, and reduce hand fatigue. Their durable stainless‑steel construction extends lifespan, delivering cost savings for...
Recent dust storms in El Paso have triggered a surge in respiratory illnesses, from asthma attacks to severe Valley fever infections. A University of California study found hospitalizations jump fivefold after dust events, while Texas does not require statewide reporting of...
Post‑COVID America faces a sustained surge in mental‑health demand, with anxiety, depression and chronic stress cases outpacing pre‑2020 levels. Simultaneously, therapist supply lags, leaving many regions designated as mental‑health professional shortage areas. Clinicians report packed schedules, waiting lists, and increasingly...
A UC Health‑wide hypertension algorithm was embedded in electronic health records for roughly 90,000 patients, raising the proportion of controlled blood pressure from 68.5% to nearly 74% by mid‑2025. The stepwise, clinician‑guided tool, called the UC Way Hypertension Medication Algorithm,...
The British Heart Foundation warned that popular gut‑friendly foods such as kimchi, sauerkraut, kombucha and fruit smoothies can pose hidden cardiovascular risks due to added salt, sugar, and low fiber. Cardiology dietitian Michelle Routhenstein clarified that while probiotic strains may...
Researchers at the University of Pennsylvania and collaborators have developed a preclinical gene therapy that selectively silences pain‑processing circuits in the brain, mimicking morphine’s analgesic effect without activating reward pathways. Using an AI‑driven system to map morphine‑responsive neurons in mice,...
A population‑based analysis of U.S. death certificates from 2020‑2022 examined Alzheimer’s disease mortality across 443 occupations. Taxi drivers (1.03% of deaths) and ambulance drivers (0.91%) showed the lowest adjusted proportions of Alzheimer‑related deaths, well below the overall adjusted rate of...
New randomized data from the Ez‑PAVE trial in South Korea show that lowering LDL cholesterol to below 55 mg/dL in patients with established atherosclerotic cardiovascular disease reduces major cardiovascular events by 33% compared with a target of less than 70 mg/dL. The...
Rural America faces a stark dermatology shortage, with 68% of counties lacking a specialist, leading to long travel distances and delayed skin‑cancer diagnoses. Experts at the 2026 AAD meeting highlighted that teledermatology, primary‑care provider (PCP) support, and mobile clinics are...
Biogen announced positive Phase 2 results for litifilimab, its anti‑BDCA2 antibody targeting systemic lupus erythematosus. After 24 weeks, 14.7% of patients achieved complete clearance of skin lesions, meeting the trial’s primary endpoint. The data suggest the drug could become a...
The phase II KARDINAL trial evaluated monthly versus single‑dose tonlamarsen, an angiotensinogen‑targeted nucleic‑acid therapy, in patients with resistant hypertension on multiple drugs. While monthly injections achieved a 67% reduction in plasma AGT compared with 23% after a single dose, both regimens...
Egypt’s medical‑tourism sector surged in 2025, with revenues jumping 76.7% to roughly $8 million. The growth is driven by a government push to market affordable, high‑quality care to nearby Gulf and African nations, leveraging the country’s tourism infrastructure. A new national...
Psilocybin therapy is rapidly expanding across U.S. states, with Oregon reporting 5,935 patients in 2025 and Colorado opening its first regulated healing center. New Mexico is developing its own medical program while the federal government maintains prohibition. Scientific evidence shows...
Takeda announced Phase 3 data for its oral TYK2 inhibitor, zasocitinib, showing rapid and durable skin clearance in moderate‑to‑severe plaque psoriasis. At week 16, 71% of patients achieved clear or almost clear skin (sPGA 0/1) versus roughly 10% on placebo and 30% on...
An 88‑year‑old civil‑rights veteran used an AI‑powered dyslexia program and saw his reading accuracy jump from 50 % to 80 % in phonemic awareness. Clinical evidence shows that neuroplasticity remains viable in seniors, allowing language‑based cognitive training to improve reading and memory...
